- Home
- TOVX vs IDAI Comparison
TOVX vs IDAI Comparison
Compare TOVX & IDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TOVX | IDAI |
|---|---|---|
| Founded | 2001 | 2016 |
| Country | United States | United States |
| Employees | N/A | 75 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.7M | 13.0M |
| IPO Year | 2012 | 2022 |
Fundamental Metrics
Financial Performance| Metric | TOVX | IDAI |
|---|---|---|
| Price | $0.23 | $2.39 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $1.00 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 1.6M | 110.7K |
| Earning Date | 05-13-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 89.07 | 76.50 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $103.06 |
| Revenue Next Year | N/A | $140.06 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.16 | $1.17 |
| 52 Week High | $0.86 | $5.28 |
Technical Indicators
Market Signals| Indicator | TOVX | IDAI |
|---|---|---|
| Relative Strength Index (RSI) | 39.75 | 62.43 |
| Support Level | $0.23 | $2.31 |
| Resistance Level | $0.27 | $2.52 |
| Average True Range (ATR) | 0.02 | 0.22 |
| MACD | -0.00 | 0.09 |
| Stochastic Oscillator | 15.32 | 95.12 |
Price Performance
Historical ComparisonAbout TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.
About IDAI T Stamp Inc.
T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility. The company operates in one reportable segment, artificial intelligence-powered solutions. The artificial intelligence-powered solutions segment generates revenue from software licenses, professional services, and recurring SaaS revenue.